These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26037169)

  • 1. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
    Conant JL; Peng Z; Evans MF; Naud S; Cooper K
    J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cumulative Analysis of Current Evidence for Association between Expression of Epithelial-Mesenchymal Transition Markers and Clinicopathological Outcomes in Patients after Radical Prostatectomy.
    Jiang G; Hu Q; Wang H; Ding W; Zhang N; Wu Y; Zhou Q; Sun C; Xia G; Ding Q; Na R; Xu K
    Ann Clin Lab Sci; 2018 Jan; 48(1):18-28. PubMed ID: 29530992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
    Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy.
    Behnsawy HM; Miyake H; Harada K; Fujisawa M
    BJU Int; 2013 Jan; 111(1):30-7. PubMed ID: 23107154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE; Bae JS; Kang MJ; Chung MJ; Jang KY; Park HS; Moon WS
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites.
    Mezi S; Chiappetta C; Carletti R; Nardini A; Cortesi E; Orsi E; Piesco G; Di Gioia C
    Head Neck; 2017 Sep; 39(9):1806-1818. PubMed ID: 28561907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
    Abouhashem NS; Ibrahim DA; Mohamed AM
    Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.
    Galván JA; Astudillo A; Vallina A; Fonseca PJ; Gómez-Izquierdo L; García-Carbonero R; González MV
    Am J Clin Pathol; 2013 Jul; 140(1):61-72. PubMed ID: 23765535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.
    Armstrong AJ; Healy P; Halabi S; Vollmer R; Lark A; Kemeny G; Ware K; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):40-5. PubMed ID: 26458958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
    Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
    De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
    Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer.
    Whiteland H; Spencer-Harty S; Thomas DH; Davies C; Morgan C; Kynaston H; Bose P; Fenn N; Lewis PD; Bodger O; Jenkins S; Doak SH
    Exp Mol Pathol; 2013 Oct; 95(2):220-6. PubMed ID: 23933194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
    Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.